Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Passes Above Two Hundred Day Moving Average – What’s Next?

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX)’s stock price crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $1.94 and traded as high as $6.05. Cumberland Pharmaceuticals shares last traded at $5.31, with a volume of 168,177 shares traded.

Wall Street Analysts Forecast Growth

Separately, StockNews.com assumed coverage on Cumberland Pharmaceuticals in a report on Friday, February 14th. They set a “hold” rating on the stock.

Cumberland Pharmaceuticals Trading Down 10.8 %

The company has a market capitalization of $74.56 million, a price-to-earnings ratio of -6.90 and a beta of 0.12. The company has a 50-day moving average price of $3.11 and a 200-day moving average price of $1.94. The company has a quick ratio of 0.99, a current ratio of 1.13 and a debt-to-equity ratio of 0.41.

Institutional Investors Weigh In On Cumberland Pharmaceuticals

An institutional investor recently raised its position in Cumberland Pharmaceuticals stock. Two Sigma Investments LP grew its holdings in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) by 94.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 37,649 shares of the specialty pharmaceutical company’s stock after purchasing an additional 18,271 shares during the quarter. Two Sigma Investments LP owned about 0.27% of Cumberland Pharmaceuticals worth $89,000 as of its most recent filing with the SEC. Hedge funds and other institutional investors own 15.51% of the company’s stock.

Cumberland Pharmaceuticals Company Profile

Cumberland Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.